Infectoopticef Saft

Cefixime, the active ingredient in Infectoopticef Saft, is a third‑generation cephalosporin presented as an oral suspension for oral use. It treats bacterial infections such as acute otitis media, acute sinusitis, acute bronchitis, uncomplicated urinary tract infection, and uncomplicated gonorrhea in appropriate patients.

GNH USA supplies Infectoopticef Saft as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Cefixime is a third‑generation cephalosporin antibiotic used to treat infections caused by susceptible bacteria in the respiratory, urinary and genital tracts.

- Acute otitis media: eliminates the causative bacteria and relieves ear‑infection symptoms. - Acute sinusitis: clears sinus inflammation by eradicating the responsible pathogens. - Acute bronchitis: reduces bacterial load in the lower airways, improving cough and sputum production. - Uncomplicated urinary tract infection: eradicates uropathogens, resolving dysuria and frequency. - Uncomplicated gonorrhea: provides bactericidal activity against Neisseria gonorrhoeae, achieving microbiological cure.

Cefixime may cause a range of adverse reactions, which are generally categorized as common or serious.

Common Side Effects: - Diarrhea: mild to moderate loose stools. - Nausea: sensation of queasiness, sometimes with vomiting. - Vomiting: expulsion of stomach contents. - Abdominal pain: cramping or discomfort in the stomach area. - Headache: mild to moderate head pain. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Anaphylaxis: rapid, life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Neutropenia: marked reduction in neutrophil count. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Severe skin reactions: toxic epidermal necrolysis.

Before prescribing Infectoopticef Saft, clinicians should consider several safety factors. - Renal impairment: assess kidney function and adjust dose if necessary. - History of β‑lactam hypersensitivity: avoid use in patients with known cephalosporin or penicillin allergy. - Pregnancy and lactation: prescribe only when the potential benefit justifies the potential risk. - Concomitant anticoagulants: monitor INR or PT values for possible enhancement of anticoagulant effect. - Use in children: dose is weight‑based and must be determined by the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Cefixime can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Probenecid: may raise cefixime plasma concentrations, increasing risk of toxicity. - Antacids containing aluminum or magnesium: can markedly reduce cefixime absorption.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect; monitor INR regularly. - Oral contraceptives: possible reduction in contraceptive efficacy; advise backup method. - Allopurinol: may increase the likelihood of rash; observe for skin reactions.